Klingensmith Harvey Robert
SEC insider (Form 3/4/5 filer). CIK 0001800107. Director at Core Laboratories Inc. /DE/ (CLB). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in HOUSTON, TX.
Companies Klingensmith Harvey Robert has filed insider reports for
- Core Laboratories Inc. /DE/ (CLB): Director
Klingensmith Harvey Robert
CIK: 0001800107
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (50.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLB
Core Laboratories Inc. /DE/
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 1, 2026CLB
Core Laboratories Inc. /DE/
ExerciseDirect8.1K shares- - Apr 1, 2026CLB
Core Laboratories Inc. /DE/
AwardDirectRestricted Shares
7.9K shares- - Apr 1, 2025CLB
Core Laboratories Inc. /DE/
ExerciseDirect9.3K shares- - Apr 1, 2025CLB
Core Laboratories Inc. /DE/
AwardDirectRestricted Shares
8.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 | CLB Core Laboratories Inc. /DE/ | Exercise | 8,069 | - | $0 | Direct |
| Apr 1, 2026 | CLB Core Laboratories Inc. /DE/ | Award Restricted Shares | 7,895 | - | - | Direct |
| Apr 1, 2025 | CLB Core Laboratories Inc. /DE/ | Exercise | 9,317 | - | - | Direct |
| Apr 1, 2025 | CLB Core Laboratories Inc. /DE/ | Award Restricted Shares | 8,069 | - | - | Direct |
1-4 of 4 transactions